2m 2m 2m 2m 2m 2m 2m
- $5.1MMarket Cap
- -68.42%1-Year Change
- Medical DevicesIndustry
REMSleep Holdngs (RMSL)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 34
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Sleep.ai announced that 10 scientific studies will be presented at SLEEP 2026, including three original AI/ML analyses on smartphone-based sleep detection and sleep apnea prediction, plus seven partner validation studies on sleep-related products. The presentations underscore Sleep.ai's commitment to evidence-based sleep innovation, leveraging over one billion hours of sleep data and 250+ scientific studies.
06/11/2026, 9:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/23/2026
Company Profile
REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.
Key Executives
- Jeffrey Marshall
- Peter Downey
- Teresita Rubio
- Irina Veselinovic
- Sanja Pekovic
Current Ownership Distribution
- Other971.6M (57.34%)
- Insiders713.6M (42.11%)
- Institutions9.4M (0.55%)
- Mutual Funds0 (0.00%)